Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36)
Clinical Information
Amikacin - A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Aminoglycosides - Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS.
Amoxicillin - A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration.
Amoxicillin-Potassium Clavulanate Combination - A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.
Amphotericin B - Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Ampicillin - Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
Ampicillin Resistance - Nonsusceptibility of a microbe to the action of ampicillin, a penicillin derivative that interferes with cell wall synthesis.
Azithromycin - A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
Azlocillin - A semisynthetic ampicillin-derived acylureido penicillin.
Aztreonam - A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
Capreomycin - Cyclic peptide antibiotic similar to VIOMYCIN. It is produced by Streptomyces capreolus.
Carbenicillin - Broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function.
Carfecillin - The phenyl ester of CARBENICILLIN that, upon oral administration, is broken down in the intestinal mucosa to the active antibacterial. It is used for urinary tract infections.
Cefaclor - Semisynthetic, broad-spectrum antibiotic derivative of CEPHALEXIN.
Cefadroxil - Long-acting, broad-spectrum, water-soluble, CEPHALEXIN derivative.
Cefamandole - Semisynthetic wide-spectrum cephalosporin with prolonged action, probably due to beta-lactamase resistance. It is used also as the nafate.
Cefatrizine - Orally active semisynthetic cephalosporin antibiotic with broad-spectrum activity.
Cefazolin - A semisynthetic cephalosporin analog with broad-spectrum antibiotic action due to inhibition of bacterial cell wall synthesis. It attains high serum levels and is excreted quickly via the urine.
Cefixime - A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
Cefmenoxime - A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of Enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Cefmetazole - A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted.
Cefonicid - A second-generation cephalosporin administered intravenously or intramuscularly. Its bactericidal action results from inhibition of cell wall synthesis. It is used for urinary tract infections, lower respiratory tract infections, and soft tissue and bone infections.
Cefoperazone - Semisynthetic broad-spectrum cephalosporin with a tetrazolyl moiety that is resistant to beta-lactamase. It may be used to treat Pseudomonas infections.
Cefotaxime - Semisynthetic broad-spectrum cephalosporin.
Cefotetan - A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms.
Cefotiam - One of the CEPHALOSPORINS that has a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
Cefoxitin - A semisynthetic cephamycin antibiotic resistant to beta-lactamase.
Cefsulodin - A pyridinium-substituted semisynthetic, broad-spectrum antibacterial used especially for Pseudomonas infections in debilitated patients.
Ceftazidime - Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients.
Ceftizoxime - A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders.
Ceftriaxone - A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears.
Cefuroxime - Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
Cephalexin - A semisynthetic cephalosporin antibiotic with antimicrobial activity similar to that of CEPHALORIDINE or CEPHALOTHIN, but somewhat less potent. It is effective against both gram-positive and gram-negative organisms.
Cephaloglycin - A cephalorsporin antibiotic.
Cephaloridine - A cephalosporin antibiotic.
Cephalosporinase - A cephalosporin antibiotic.
Cephalosporins - A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid.
Cephalothin - A cephalosporin antibiotic.
Cephradine - A semi-synthetic cephalosporin antibiotic.
Chloramphenicol - An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106)
Chloramphenicol O-Acetyltransferase - An enzyme that catalyzes the acetylation of chloramphenicol to yield chloramphenicol 3-acetate. Since chloramphenicol 3-acetate does not bind to bacterial ribosomes and is not an inhibitor of peptidyltransferase, the enzyme is responsible for the naturally occurring chloramphenicol resistance in bacteria. The enzyme, for which variants are known, is found in both gram-negative and gram-positive bacteria. EC 2.3.1.28.
Chloramphenicol Resistance - Nonsusceptibility of bacteria to the action of CHLORAMPHENICOL, a potent inhibitor of protein synthesis in the 50S ribosomal subunit where amino acids are added to nascent bacterial polypeptides.
Chlortetracycline - A TETRACYCLINE with a 7-chloro substitution.
Cilastatin, Imipenem Drug Combination - Combination of imipenem and cilastatin that is used in the treatment of bacterial infections; cilastatin inhibits renal dehydropeptidase I to prolong the half-life and increase the tissue penetration of imipenem, enhancing its efficacy as an anti-bacterial agent.
Ciprofloxacin - A broad-spectrum antimicrobial carboxyfluoroquinoline.
Clavulanic Acid - A beta-lactam antibiotic produced by the actinobacterium Streptomyces clavuligerus. It is a suicide inhibitor of bacterial beta-lactamase enzymes. Administered alone, it has only weak antibacterial activity against most organisms, but given in combination with other beta-lactam antibiotics it prevents antibiotic inactivation by microbial lactamase.
Clavulanic Acids - Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects.
Clindamycin - An antibacterial agent that is a semisynthetic analog of LINCOMYCIN.
Cloxacillin - A semi-synthetic antibiotic that is a chlorinated derivative of OXACILLIN.
Colistin - Cyclic polypeptide antibiotic from Bacillus colistinus. It is composed of Polymyxins E1 and E2 (or Colistins A, B, and C) which act as detergents on cell membranes. Colistin is less toxic than Polymyxin B, but otherwise similar; the methanesulfonate is used orally.
Cyclacillin - A cyclohexylamido analog of PENICILLANIC ACID.
Demeclocycline - A TETRACYCLINE analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time.
Dibekacin - Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties.
Dicloxacillin - One of the PENICILLINS which is resistant to PENICILLINASE.
Doxycycline - A synthetic tetracycline derivative with similar antimicrobial activity.
Enoxacin - A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
Enviomycin - Cyclic basic peptide related to VIOMYCIN. It is isolated from an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.
First Generation Cephalosporins - CEPHALOSPORIN agents with excellent coverage against gram-positive cocci, such as STAPHYLOCOCCUS and STREPTOCOCCUS. They have some activity against the gram-negative bacteria, but in general, gram-negative activity is decreased compared to 2nd, 3rd, and 4th generation cephalosporins.
Fleroxacin - A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
Fosfomycin - An antibiotic produced by Streptomyces fradiae.
Framycetin - A component of NEOMYCIN that is produced by Streptomyces fradiae. On hydrolysis it yields neamine and neobiosamine B. (From Merck Index, 11th ed)
Fusidic Acid - An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed). It acts by inhibiting translocation during protein synthesis.
Griseofulvin - An antifungal agent used in the treatment of TINEA infections.
Imipenem - Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Josamycin - A macrolide antibiotic from Streptomyces narbonensis. The drug has antimicrobial activity against a wide spectrum of pathogens.
Kanamycin - Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components.
Kanamycin Kinase - A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics (AMINOGLYCOSIDES) by regiospecific PHOSPHORYLATION of the 3' and/or 5' hydroxyl.
Kanamycin Resistance - Nonsusceptibility of bacteria to the antibiotic KANAMYCIN, which can bind to their 70S ribosomes and cause misreading of messenger RNA.
Kitasamycin - A macrolide antibiotic produced by Streptomyces kitasatoensis. The drug has antimicrobial activity against a wide spectrum of pathogens.
Levofloxacin - The L-isomer of Ofloxacin.
Lincomycin - An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.
Lymecycline - A semisynthetic antibiotic related to TETRACYCLINE. It is more readily absorbed than TETRACYCLINE and can be used in lower doses.
Macrolides - A group of often glycosylated macrocyclic compounds formed by chain extension of multiple PROPIONATES cyclized into a large (typically 12, 14, or 16)-membered lactone. Macrolides belong to the POLYKETIDES class of natural products, and many members exhibit ANTIBIOTIC properties.
Mepartricin - Polyene macrolide antibiotic with unknown composition. It is obtained from Streptomyces aureofaciens. It is used as an antifungal agent, an antiprotozoal agent, and in the treatment of BENIGN PROSTATIC HYPERTROPHY.
Methacycline - A broad-spectrum semisynthetic antibiotic related to TETRACYCLINE but excreted more slowly and maintaining effective blood levels for a more extended period.
Methicillin - One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection.
Methicillin Resistance - Non-susceptibility of a microbe to the action of METHICILLIN, a semi-synthetic penicillin derivative.
Methicillin-Resistant Staphylococcus aureus - A strain of Staphylococcus aureus that is non-susceptible to the action of METHICILLIN. The mechanism of resistance usually involves modification of normal or the presence of acquired PENICILLIN BINDING PROTEINS.
Mezlocillin - Semisynthetic ampicillin-derived acylureido penicillin. It has been proposed for infections with certain anaerobes and may be useful in inner ear, bile, and CNS infections.
Minocycline - A TETRACYCLINE analog, having a 7-dimethylamino and lacking the 5 methyl and hydroxyl groups, which is effective against tetracycline-resistant STAPHYLOCOCCUS infections.
Nafcillin - A semi-synthetic antibiotic related to penicillin.
Netilmicin - Semisynthetic 1-N-ethyl derivative of SISOMYCIN, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity.
Norfloxacin - A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
Novobiocin - An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189)
Nystatin - Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.
Ofloxacin - A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
Oleandomycin - Antibiotic macrolide produced by Streptomyces antibioticus.
Oxacillin - An antibiotic similar to FLUCLOXACILLIN used in resistant staphylococci infections.
Oxytetracycline - A TETRACYCLINE analog isolated from the actinomycete STREPTOMYCES RIMOSUS and used in a wide variety of clinical conditions.
Paromomycin - An aminoglycoside antibacterial and antiprotozoal agent produced by species of STREPTOMYCES.
Penicillinase - A beta-lactamase preferentially cleaving penicillins. (Dorland, 28th ed) EC 3.5.2.-.
Penicillins - A group of antibiotics that contain 6-aminopenicillanic acid with a side chain attached to the 6-amino group. The penicillin nucleus is the chief structural requirement for biological activity. The side-chain structure determines many of the antibacterial and pharmacological characteristics. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1065)
Piperacillin - Semisynthetic, broad-spectrum, AMPICILLIN derived ureidopenicillin antibiotic proposed for PSEUDOMONAS infections. It is also used in combination with other antibiotics.
Piperacillin, Tazobactam Drug Combination - An antibiotic combination product of piperacillin and tazobactam, a penicillanic acid derivative with enhanced beta-lactamase inhibitory activity, that is used for the intravenous treatment of intra-abdominal, pelvic, and skin infections and for community-acquired pneumonia of moderate severity. It is also used for the treatment of PSEUDOMONAS AERUGINOSA INFECTIONS.
Pivampicillin - Pivalate ester analog of AMPICILLIN.
Pristinamycin - An antibiotic mixture originally isolated from Streptomyces pristinaspiralis. It is a mixture of compounds from STREPTOGRAMIN GROUP A: pristinamycin IIA and IIB and from STREPTOGRAMIN GROUP B: pristinamycin IA, pristinamycin IB, pristinamycin IC.
Ribostamycin - A broad-spectrum antimicrobial isolated from Streptomyces ribosifidicus.
Rifabutin - A broad-spectrum antibiotic that is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Rifampin - A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160)
Rifaximin - A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of GASTROENTERITIS caused by ESCHERICHIA COLI INFECTIONS. It may also be used in the treatment of HEPATIC ENCEPHALOPATHY.
Ristocetin - An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.
Rolitetracycline - A pyrrolidinylmethyl TETRACYCLINE.
Roxithromycin - Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.
Second Generation Cephalosporins - Agents with less activity against gram-positive cocci than FIRST GENERATION CEPHALOSPORINS but have increased activity against gram-negative bacilli.
Sisomicin - Antibiotic produced by Micromonospora inyoensis. It is closely related to gentamicin C1A, one of the components of the gentamicin complex (GENTAMICINS).
Spectinomycin - An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA.
Spiramycin - A macrolide antibiotic produced by Streptomyces ambofaciens. The drug is effective against gram-positive aerobic pathogens, N. gonorrhoeae, and staphylococci. It is used to treat infections caused by bacteria and Toxoplasma gondii.
Streptogramin A - A specific streptogramin group A antibiotic produced by Streptomyces graminofaciens and other bacteria.
Streptogramin B - A specific streptogramin group B antibiotic produced by Streptomyces graminofaciens and other bacteria.
Sulbactam - A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.
Sulbenicillin - Semisynthetic penicillin-type antibiotic.
Talampicillin - An ester of AMPICILLIN which is readily hydrolyzed on absorption to release ampicillin. It is well absorbed from the gastrointestinal tract resulting in a greater bioavailability of ampicillin than can be achieved with equivalent doses of ampicillin.
Teicoplanin - Lipoglycopeptide antibiotic from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.
Tetracycline - A naphthacene antibiotic that inhibits AMINO ACYL TRNA binding during protein synthesis.
Tetracycline Resistance - Nonsusceptibility of bacteria to the action of TETRACYCLINE which inhibits aminoacyl-tRNA binding to the 30S ribosomal subunit during protein synthesis.
Tetracyclines - Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
Thiamphenicol - A methylsulfonyl analog of CHLORAMPHENICOL. It is an antibiotic and immunosuppressive agent.
Third Generation Cephalosporins - Agents that are structurally similar to other CEPHALOSPORINS but have a broader spectrum of activity against bacteria than the first and second generation cephalosporins. These agents cover more resistant STREPTOCOCCUS, STAPHYLOCOCCUS, gram-positive anaerobes, and more resistant strains of HAEMOPHILUS, NEISSERIA, PROTEUS, ESCHERICHIA COLI, and KLEBSIELLA (HNPEK).
Ticarcillin - An antibiotic derived from penicillin similar to CARBENICILLIN in action.
Tobramycin - An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
Tobramycin, Dexamethasone Drug Combination - A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye.
Troleandomycin - A macrolide antibiotic that is similar to ERYTHROMYCIN.
Vancomycin - Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear.
Vancomycin Resistance - Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.
Vancomycin-Resistant Enterococci - Strains of the genus Enterococcus that are resistant to the antibiotic VANCOMYCIN. The enterococci become resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE.
Vancomycin-Resistant Staphylococcus aureus - Isolates of the Staphylococcus aureus that are resistant to the antibiotic VANCOMYCIN. The S. aureus becomes resistant by acquiring plasmids carrying genes for VANCOMYCIN RESISTANCE. Vancomycin‐intermediate S. aureus has low-level vancomycin resistance requiring an intermediate concentration of vancomycin between sensitive and resistant isolates. These S. aureus with reduced susceptibility to vancomycin and related GLYCOPEPTIDE antibiotics are often seen in HEALTHCARE ASSOCIATED INFECTIONS.
Viomycin - A strongly basic peptide, antibiotic complex from several strains of Streptomyces. It is allergenic and toxic to kidneys and the labyrinth. Viomycin is used in tuberculosis as several different salts and in combination with other agents.
Virginiamycin - A cyclic polypeptide antibiotic complex from Streptomyces virginiae, S. loidensis, S. mitakaensis, S. pristina-spiralis, S. ostreogriseus, and others. It consists of 2 major components, VIRGINIAMYCIN FACTOR M1 and virginiamycin Factor S1. It is used to treat infections with gram-positive organisms and as a growth promoter in cattle, swine, and poultry.
von Willebrand Factor - A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor.
Instructional Notations
Type 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- antineoplastic antibiotics T45.1
- locally applied antibiotic NEC T49.0
- topically used antibiotic for ear, nose and throat T49.6
- topically used antibiotic for eye T49.5
7th Character Note
Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
- The appropriate 7th character is to be added to each code from category T36
7th Character
Indicates that a seventh character is to be assigned to codes in a subcategory.
- A - initial encounter
- D - subsequent encounter
- S - sequela
Injury, poisoning and certain other consequences of external causes (S00–T88)
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
T36 Poisoning by, adverse effect of and underdosing of systemic antibiotics
T36.0 Poisoning by, adverse effect of and underdosing of penicillins
T36.0X Poisoning by, adverse effect of and underdosing of penicillins
T36.0X1 Poisoning by penicillins, accidental (unintentional)
- T36.0X1A Poisoning by penicillins, accidental (unintentional), initial encounter
- T36.0X1D Poisoning by penicillins, accidental (unintentional), subsequent encounter
- T36.0X1S Poisoning by penicillins, accidental (unintentional), sequela
T36.0X2 Poisoning by penicillins, intentional self-harm
- T36.0X2A Poisoning by penicillins, intentional self-harm, initial encounter
- T36.0X2D Poisoning by penicillins, intentional self-harm, subsequent encounter
- T36.0X2S Poisoning by penicillins, intentional self-harm, sequela
T36.0X3 Poisoning by penicillins, assault
- T36.0X3A Poisoning by penicillins, assault, initial encounter
- T36.0X3D Poisoning by penicillins, assault, subsequent encounter
- T36.0X3S Poisoning by penicillins, assault, sequela
T36.0X4 Poisoning by penicillins, undetermined
- T36.0X4A Poisoning by penicillins, undetermined, initial encounter
- T36.0X4D Poisoning by penicillins, undetermined, subsequent encounter
- T36.0X4S Poisoning by penicillins, undetermined, sequela
T36.0X5 Adverse effect of penicillins
- T36.0X5A Adverse effect of penicillins, initial encounter
- T36.0X5D Adverse effect of penicillins, subsequent encounter
- T36.0X5S Adverse effect of penicillins, sequela
T36.0X6 Underdosing of penicillins
- T36.0X6A Underdosing of penicillins, initial encounter
- T36.0X6D Underdosing of penicillins, subsequent encounter
- T36.0X6S Underdosing of penicillins, sequela
T36.1 Poisoning by, adverse effect of and underdosing of cephalosporins and other beta-lactam antibiotics
T36.1X Poisoning by, adverse effect of and underdosing of cephalosporins and other beta-lactam antibiotics
T36.1X1 Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional)
- T36.1X1A Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), initial encounter
- T36.1X1D Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), subsequent encounter
- T36.1X1S Poisoning by cephalosporins and other beta-lactam antibiotics, accidental (unintentional), sequela
T36.1X2 Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm
- T36.1X2A Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, initial encounter
- T36.1X2D Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, subsequent encounter
- T36.1X2S Poisoning by cephalosporins and other beta-lactam antibiotics, intentional self-harm, sequela
T36.1X3 Poisoning by cephalosporins and other beta-lactam antibiotics, assault
- T36.1X3A Poisoning by cephalosporins and other beta-lactam antibiotics, assault, initial encounter
- T36.1X3D Poisoning by cephalosporins and other beta-lactam antibiotics, assault, subsequent encounter
- T36.1X3S Poisoning by cephalosporins and other beta-lactam antibiotics, assault, sequela
T36.1X4 Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined
- T36.1X4A Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, initial encounter
- T36.1X4D Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, subsequent encounter
- T36.1X4S Poisoning by cephalosporins and other beta-lactam antibiotics, undetermined, sequela
T36.1X5 Adverse effect of cephalosporins and other beta-lactam antibiotics
- T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X5D Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
T36.1X6 Underdosing of cephalosporins and other beta-lactam antibiotics
- T36.1X6A Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter
- T36.1X6D Underdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter
- T36.1X6S Underdosing of cephalosporins and other beta-lactam antibiotics, sequela
T36.2 Poisoning by, adverse effect of and underdosing of chloramphenicol group
T36.2X Poisoning by, adverse effect of and underdosing of chloramphenicol group
T36.2X1 Poisoning by chloramphenicol group, accidental (unintentional)
- T36.2X1A Poisoning by chloramphenicol group, accidental (unintentional), initial encounter
- T36.2X1D Poisoning by chloramphenicol group, accidental (unintentional), subsequent encounter
- T36.2X1S Poisoning by chloramphenicol group, accidental (unintentional), sequela
T36.2X2 Poisoning by chloramphenicol group, intentional self-harm
- T36.2X2A Poisoning by chloramphenicol group, intentional self-harm, initial encounter
- T36.2X2D Poisoning by chloramphenicol group, intentional self-harm, subsequent encounter
- T36.2X2S Poisoning by chloramphenicol group, intentional self-harm, sequela
T36.2X3 Poisoning by chloramphenicol group, assault
- T36.2X3A Poisoning by chloramphenicol group, assault, initial encounter
- T36.2X3D Poisoning by chloramphenicol group, assault, subsequent encounter
- T36.2X3S Poisoning by chloramphenicol group, assault, sequela
T36.2X4 Poisoning by chloramphenicol group, undetermined
- T36.2X4A Poisoning by chloramphenicol group, undetermined, initial encounter
- T36.2X4D Poisoning by chloramphenicol group, undetermined, subsequent encounter
- T36.2X4S Poisoning by chloramphenicol group, undetermined, sequela
T36.2X5 Adverse effect of chloramphenicol group
- T36.2X5A Adverse effect of chloramphenicol group, initial encounter
- T36.2X5D Adverse effect of chloramphenicol group, subsequent encounter
- T36.2X5S Adverse effect of chloramphenicol group, sequela
T36.2X6 Underdosing of chloramphenicol group
- T36.2X6A Underdosing of chloramphenicol group, initial encounter
- T36.2X6D Underdosing of chloramphenicol group, subsequent encounter
- T36.2X6S Underdosing of chloramphenicol group, sequela
T36.3 Poisoning by, adverse effect of and underdosing of macrolides
T36.3X Poisoning by, adverse effect of and underdosing of macrolides
T36.3X1 Poisoning by macrolides, accidental (unintentional)
- T36.3X1A Poisoning by macrolides, accidental (unintentional), initial encounter
- T36.3X1D Poisoning by macrolides, accidental (unintentional), subsequent encounter
- T36.3X1S Poisoning by macrolides, accidental (unintentional), sequela
T36.3X2 Poisoning by macrolides, intentional self-harm
- T36.3X2A Poisoning by macrolides, intentional self-harm, initial encounter
- T36.3X2D Poisoning by macrolides, intentional self-harm, subsequent encounter
- T36.3X2S Poisoning by macrolides, intentional self-harm, sequela
T36.3X3 Poisoning by macrolides, assault
- T36.3X3A Poisoning by macrolides, assault, initial encounter
- T36.3X3D Poisoning by macrolides, assault, subsequent encounter
- T36.3X3S Poisoning by macrolides, assault, sequela
T36.3X4 Poisoning by macrolides, undetermined
- T36.3X4A Poisoning by macrolides, undetermined, initial encounter
- T36.3X4D Poisoning by macrolides, undetermined, subsequent encounter
- T36.3X4S Poisoning by macrolides, undetermined, sequela
T36.3X5 Adverse effect of macrolides
- T36.3X5A Adverse effect of macrolides, initial encounter
- T36.3X5D Adverse effect of macrolides, subsequent encounter
- T36.3X5S Adverse effect of macrolides, sequela
T36.3X6 Underdosing of macrolides
- T36.3X6A Underdosing of macrolides, initial encounter
- T36.3X6D Underdosing of macrolides, subsequent encounter
- T36.3X6S Underdosing of macrolides, sequela
T36.4 Poisoning by, adverse effect of and underdosing of tetracyclines
T36.4X Poisoning by, adverse effect of and underdosing of tetracyclines
T36.4X1 Poisoning by tetracyclines, accidental (unintentional)
- T36.4X1A Poisoning by tetracyclines, accidental (unintentional), initial encounter
- T36.4X1D Poisoning by tetracyclines, accidental (unintentional), subsequent encounter
- T36.4X1S Poisoning by tetracyclines, accidental (unintentional), sequela
T36.4X2 Poisoning by tetracyclines, intentional self-harm
- T36.4X2A Poisoning by tetracyclines, intentional self-harm, initial encounter
- T36.4X2D Poisoning by tetracyclines, intentional self-harm, subsequent encounter
- T36.4X2S Poisoning by tetracyclines, intentional self-harm, sequela
T36.4X3 Poisoning by tetracyclines, assault
- T36.4X3A Poisoning by tetracyclines, assault, initial encounter
- T36.4X3D Poisoning by tetracyclines, assault, subsequent encounter
- T36.4X3S Poisoning by tetracyclines, assault, sequela
T36.4X4 Poisoning by tetracyclines, undetermined
- T36.4X4A Poisoning by tetracyclines, undetermined, initial encounter
- T36.4X4D Poisoning by tetracyclines, undetermined, subsequent encounter
- T36.4X4S Poisoning by tetracyclines, undetermined, sequela
T36.4X5 Adverse effect of tetracyclines
- T36.4X5A Adverse effect of tetracyclines, initial encounter
- T36.4X5D Adverse effect of tetracyclines, subsequent encounter
- T36.4X5S Adverse effect of tetracyclines, sequela
T36.4X6 Underdosing of tetracyclines
- T36.4X6A Underdosing of tetracyclines, initial encounter
- T36.4X6D Underdosing of tetracyclines, subsequent encounter
- T36.4X6S Underdosing of tetracyclines, sequela
T36.5 Poisoning by, adverse effect of and underdosing of aminoglycosides
T36.5X Poisoning by, adverse effect of and underdosing of aminoglycosides
T36.5X1 Poisoning by aminoglycosides, accidental (unintentional)
- T36.5X1A Poisoning by aminoglycosides, accidental (unintentional), initial encounter
- T36.5X1D Poisoning by aminoglycosides, accidental (unintentional), subsequent encounter
- T36.5X1S Poisoning by aminoglycosides, accidental (unintentional), sequela
T36.5X2 Poisoning by aminoglycosides, intentional self-harm
- T36.5X2A Poisoning by aminoglycosides, intentional self-harm, initial encounter
- T36.5X2D Poisoning by aminoglycosides, intentional self-harm, subsequent encounter
- T36.5X2S Poisoning by aminoglycosides, intentional self-harm, sequela
T36.5X3 Poisoning by aminoglycosides, assault
- T36.5X3A Poisoning by aminoglycosides, assault, initial encounter
- T36.5X3D Poisoning by aminoglycosides, assault, subsequent encounter
- T36.5X3S Poisoning by aminoglycosides, assault, sequela
T36.5X4 Poisoning by aminoglycosides, undetermined
- T36.5X4A Poisoning by aminoglycosides, undetermined, initial encounter
- T36.5X4D Poisoning by aminoglycosides, undetermined, subsequent encounter
- T36.5X4S Poisoning by aminoglycosides, undetermined, sequela
T36.5X5 Adverse effect of aminoglycosides
- T36.5X5A Adverse effect of aminoglycosides, initial encounter
- T36.5X5D Adverse effect of aminoglycosides, subsequent encounter
- T36.5X5S Adverse effect of aminoglycosides, sequela
T36.5X6 Underdosing of aminoglycosides
- T36.5X6A Underdosing of aminoglycosides, initial encounter
- T36.5X6D Underdosing of aminoglycosides, subsequent encounter
- T36.5X6S Underdosing of aminoglycosides, sequela
T36.6 Poisoning by, adverse effect of and underdosing of rifampicins
T36.6X Poisoning by, adverse effect of and underdosing of rifampicins
T36.6X1 Poisoning by rifampicins, accidental (unintentional)
- T36.6X1A Poisoning by rifampicins, accidental (unintentional), initial encounter
- T36.6X1D Poisoning by rifampicins, accidental (unintentional), subsequent encounter
- T36.6X1S Poisoning by rifampicins, accidental (unintentional), sequela
T36.6X2 Poisoning by rifampicins, intentional self-harm
- T36.6X2A Poisoning by rifampicins, intentional self-harm, initial encounter
- T36.6X2D Poisoning by rifampicins, intentional self-harm, subsequent encounter
- T36.6X2S Poisoning by rifampicins, intentional self-harm, sequela
T36.6X3 Poisoning by rifampicins, assault
- T36.6X3A Poisoning by rifampicins, assault, initial encounter
- T36.6X3D Poisoning by rifampicins, assault, subsequent encounter
- T36.6X3S Poisoning by rifampicins, assault, sequela
T36.6X4 Poisoning by rifampicins, undetermined
- T36.6X4A Poisoning by rifampicins, undetermined, initial encounter
- T36.6X4D Poisoning by rifampicins, undetermined, subsequent encounter
- T36.6X4S Poisoning by rifampicins, undetermined, sequela
T36.6X5 Adverse effect of rifampicins
- T36.6X5A Adverse effect of rifampicins, initial encounter
- T36.6X5D Adverse effect of rifampicins, subsequent encounter
- T36.6X5S Adverse effect of rifampicins, sequela
T36.6X6 Underdosing of rifampicins
- T36.6X6A Underdosing of rifampicins, initial encounter
- T36.6X6D Underdosing of rifampicins, subsequent encounter
- T36.6X6S Underdosing of rifampicins, sequela
T36.7 Poisoning by, adverse effect of and underdosing of antifungal antibiotics, systemically used
T36.7X Poisoning by, adverse effect of and underdosing of antifungal antibiotics, systemically used
T36.7X1 Poisoning by antifungal antibiotics, systemically used, accidental (unintentional)
- T36.7X1A Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), initial encounter
- T36.7X1D Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), subsequent encounter
- T36.7X1S Poisoning by antifungal antibiotics, systemically used, accidental (unintentional), sequela
T36.7X2 Poisoning by antifungal antibiotics, systemically used, intentional self-harm
- T36.7X2A Poisoning by antifungal antibiotics, systemically used, intentional self-harm, initial encounter
- T36.7X2D Poisoning by antifungal antibiotics, systemically used, intentional self-harm, subsequent encounter
- T36.7X2S Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela
T36.7X3 Poisoning by antifungal antibiotics, systemically used, assault
- T36.7X3A Poisoning by antifungal antibiotics, systemically used, assault, initial encounter
- T36.7X3D Poisoning by antifungal antibiotics, systemically used, assault, subsequent encounter
- T36.7X3S Poisoning by antifungal antibiotics, systemically used, assault, sequela
T36.7X4 Poisoning by antifungal antibiotics, systemically used, undetermined
- T36.7X4A Poisoning by antifungal antibiotics, systemically used, undetermined, initial encounter
- T36.7X4D Poisoning by antifungal antibiotics, systemically used, undetermined, subsequent encounter
- T36.7X4S Poisoning by antifungal antibiotics, systemically used, undetermined, sequela
T36.7X5 Adverse effect of antifungal antibiotics, systemically used
- T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
- T36.7X5D Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X5S Adverse effect of antifungal antibiotics, systemically used, sequela
T36.7X6 Underdosing of antifungal antibiotics, systemically used
- T36.7X6A Underdosing of antifungal antibiotics, systemically used, initial encounter
- T36.7X6D Underdosing of antifungal antibiotics, systemically used, subsequent encounter
- T36.7X6S Underdosing of antifungal antibiotics, systemically used, sequela
T36.8 Poisoning by, adverse effect of and underdosing of other systemic antibiotics
T36.8X Poisoning by, adverse effect of and underdosing of other systemic antibiotics
T36.8X1 Poisoning by other systemic antibiotics, accidental (unintentional)
- T36.8X1A Poisoning by other systemic antibiotics, accidental (unintentional), initial encounter
- T36.8X1D Poisoning by other systemic antibiotics, accidental (unintentional), subsequent encounter
- T36.8X1S Poisoning by other systemic antibiotics, accidental (unintentional), sequela
T36.8X2 Poisoning by other systemic antibiotics, intentional self-harm
- T36.8X2A Poisoning by other systemic antibiotics, intentional self-harm, initial encounter
- T36.8X2D Poisoning by other systemic antibiotics, intentional self-harm, subsequent encounter
- T36.8X2S Poisoning by other systemic antibiotics, intentional self-harm, sequela
T36.8X3 Poisoning by other systemic antibiotics, assault
- T36.8X3A Poisoning by other systemic antibiotics, assault, initial encounter
- T36.8X3D Poisoning by other systemic antibiotics, assault, subsequent encounter
- T36.8X3S Poisoning by other systemic antibiotics, assault, sequela
T36.8X4 Poisoning by other systemic antibiotics, undetermined
- T36.8X4A Poisoning by other systemic antibiotics, undetermined, initial encounter
- T36.8X4D Poisoning by other systemic antibiotics, undetermined, subsequent encounter
- T36.8X4S Poisoning by other systemic antibiotics, undetermined, sequela
T36.8X5 Adverse effect of other systemic antibiotics
- T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
- T36.8X5D Adverse effect of other systemic antibiotics, subsequent encounter
- T36.8X5S Adverse effect of other systemic antibiotics, sequela
T36.8X6 Underdosing of other systemic antibiotics
- T36.8X6A Underdosing of other systemic antibiotics, initial encounter
- T36.8X6D Underdosing of other systemic antibiotics, subsequent encounter
- T36.8X6S Underdosing of other systemic antibiotics, sequela
T36.9 Poisoning by, adverse effect of and underdosing of unspecified systemic antibiotic
T36.91 Poisoning by unspecified systemic antibiotic, accidental (unintentional)
- T36.91XA Poisoning by unspecified systemic antibiotic, accidental (unintentional), initial encounter
- T36.91XD Poisoning by unspecified systemic antibiotic, accidental (unintentional), subsequent encounter
- T36.91XS Poisoning by unspecified systemic antibiotic, accidental (unintentional), sequela
T36.92 Poisoning by unspecified systemic antibiotic, intentional self-harm
- T36.92XA Poisoning by unspecified systemic antibiotic, intentional self-harm, initial encounter
- T36.92XD Poisoning by unspecified systemic antibiotic, intentional self-harm, subsequent encounter
- T36.92XS Poisoning by unspecified systemic antibiotic, intentional self-harm, sequela
T36.93 Poisoning by unspecified systemic antibiotic, assault
- T36.93XA Poisoning by unspecified systemic antibiotic, assault, initial encounter
- T36.93XD Poisoning by unspecified systemic antibiotic, assault, subsequent encounter
- T36.93XS Poisoning by unspecified systemic antibiotic, assault, sequela
T36.94 Poisoning by unspecified systemic antibiotic, undetermined
- T36.94XA Poisoning by unspecified systemic antibiotic, undetermined, initial encounter
- T36.94XD Poisoning by unspecified systemic antibiotic, undetermined, subsequent encounter
- T36.94XS Poisoning by unspecified systemic antibiotic, undetermined, sequela
T36.95 Adverse effect of unspecified systemic antibiotic
- T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
- T36.95XD Adverse effect of unspecified systemic antibiotic, subsequent encounter
- T36.95XS Adverse effect of unspecified systemic antibiotic, sequela
T36.96 Underdosing of unspecified systemic antibiotic
- T36.96XA Underdosing of unspecified systemic antibiotic, initial encounter
- T36.96XD Underdosing of unspecified systemic antibiotic, subsequent encounter
- T36.96XS Underdosing of unspecified systemic antibiotic, sequela
Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36)